News

  • 6 September 2019

    OncoCyte agrees to acquire stake in Razor Genomics

    Cancer diagnostic tests developer OncoCyte has signed a definitive agreement to acquire 25% of the outstanding shares of Razor Genomics, which offers treatment stratification test for lung cancer.

  • 4 September 2019

    DePuy Synthes to acquire assets of JointPoint

    DePuy Synthes Products, a unit of Johnson & Johnson Medical Devices Companies, will acquire the assets of JointPoint to enhance surgical accuracy and reproducibility in hip replacement.

Close
Close
Close